Hai Zou
- Hepatology top 5%
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 10
-
- RNA Interference and Gene Delivery 4
- RNA modifications and cancer 4
-
- Cancer Research and Treatments 7
-
- Virus-based gene therapy research 6
-
- Nanoplatforms for cancer theranostics 4
-
- COVID-19 Clinical Research Studies 4
-
- Advanced materials and composites 3
- Co-authors
- Xiaozhou MouYahui DingDongsheng HuangMing‐Hua ZhengWenjun WangXiaochen DongHui LiXuejiao Song
- Cited by
- HepatologyCancer ResearchImmunology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hai Zou
71 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 120
- Hepatology 154
- Cancer Research 146
- Immunology 201
- Epidemiology 299
- Molecular Biology 546
Countries citing papers authored by Hai Zou
This map shows the geographic impact of Hai Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Zou more than expected).
Fields of papers citing papers by Hai Zou
This network shows the impact of papers produced by Hai Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Zou. The network helps show where Hai Zou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hai Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 15 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 59 | |
| 12 | 2021 | 215 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 10 | |
| 15 | 2017 | 13 | |
| 16 | 2016 | 5 | |
| 17 | 2016 | 15 | |
| 18 | 2016 | 52 | |
| 19 | 2015 | 56 | |
| 20 | 2015 | 36 |
About Hai Zou
Hai Zou is a scholar working on Biotechnology, Hepatology and Pharmacology, having authored 76 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Cancer Research and Treatments (7 papers), Virus-based gene therapy research (6 papers), RNA Interference and Gene Delivery (4 papers), Nanoplatforms for cancer theranostics (4 papers), RNA modifications and cancer (4 papers), COVID-19 Clinical Research Studies (4 papers) and Advanced materials and composites (3 papers). The work is most often cited by research in Hepatology (154 citations), Cancer Research (146 citations) and Immunology (201 citations). Hai Zou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaozhou Mou, Yahui Ding, Dongsheng Huang, Ming‐Hua Zheng, Wenjun Wang, Xiaochen Dong, Hui Li, Xuejiao Song, Nan Yang and Jinjun Shao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.